Peripheral B cell receptor editing may promote the production of high-affinity autoantibodies in CD22-deficient mice

European Journal of Immunology

Volumn 36, Issue 10, 2006, Pages 2755-2767

  Yarkoni, Yuval ^a   Fischel, Ruth ^a   Kat, Inbal ^a   Yachimovich Cohen, Nurit ^a   Eilat, Dan ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Autoantibodies; Autoimmunity; B cells; Systemic lupus erythematosus; Tolerance

Indexed keywords

AUTOANTIBODY; B LYMPHOCYTE RECEPTOR; CD22 ANTIGEN; DNA ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN;

AGE; ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CELL ISOLATION; CELL SURFACE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; GENDER; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOMATIC MUTATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIBODY AFFINITY; ANTIGENS, CD22; AUTOANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTES; FEMALE; GENE REARRANGEMENT, B-LYMPHOCYTE; IMMUNE TOLERANCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICE; MICE, TRANSGENIC; MODELS, IMMUNOLOGICAL; MUTATION; RECEPTORS, ANTIGEN, B-CELL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA EDITING;

EID: 33750266512     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636190     Document Type: Article

References (70)

1. Kotzin, B. L., Systemic lupus erythematosus. Cell 1996. 85: 303-306.
2. Radic, M. Z. and Weigert, M., Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu. Rev. Immunol. 1994. 12: 487-520.
3. Eilat, D. and Anderson, W. F., Structure-function correlates of auto-antibodies to nucleic acids. Lessons from immunochemical, genetic and structural studies. Mol. Immunol. 1994. 31: 1377-1390.
4. Theofilopoulos, A. N. and Dixon, F. J., Murine models of systemic lupus erythematosus. Adv. Immunol. 1985. 37: 269-390.
5. Hahn, B., Animal models of systemic lupus erythematosus. In Wallace, D. and Hahn, B. (Eds) Dubois' Lupus Erythematosus. Lea & Febiger, Philadelphia 1993, 157-177.
6. Wakeland, E. K., Liu, K., Graham, R. R. and Behrens, T. W., Delineating the genetic basis of systemic lupus erythematosus. Immunity 2001. 15: 397-408.
7. Walport, M. J., Lupus, DNase and defective disposal of cellular debris. Nat. Genet. 2000. 25: 135-136.
8. Tedder, T. F., Tuscano, J., Sato, S. and Kehrl, J. H., CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling. Annu. Rev. Immunol. 1997. 15: 481-504.
9. Erickson, L. D., Tygrett, L. T., Bhatia, S. K., Grabstein, K. H. and Waldschmidt, T. J., Differential expression of CD22 (Lyb8) on murine B cells. Int. Immunol. 1996. 8: 1121-1129.
10. Doody, G. M., Justement, L. B., Delibrias, C. C., Matthews, R. J., Lin, J., Thomas, M. L. and Fearon, D. T., A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 1995. 269: 242-244.
11. Cyster, J. G. and Goodnow, C. C., Tuning antigen receptor signaling by CD22: Integrating cues from antigens and the microenvironment. Immunity 1997. 6: 509-517.
12. O'Keefe, T. L., Williams, G. T., Davies, S. L. and Neuberger, M. S., Hyperresponsive B cells in CD22-deficient mice. Science 1996. 274: 798-801.
13. Otipoby, K. L., Andersson, K. B., Draves, K. E., Klaus, S. J., Farr, A. G., Kerner, J. D., Perlmutter, R. M. et al., CD22 regulates thymus-independent responses and the lifespan of B cells. Nature 1996. 384: 634-637.
14. Sato, S., Miller, A. S., Inaoki, M., Bock, C. B., Jansen, P. J., Tang, M. L. and Tedder, T. F., CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: Altered signaling in CD22-deficient mice. Immunity 1996. 5: 551-562.
15. Nitschke, L., Carsetti, R., Ocker, B., Kohler, G. and Lamers, M. C., CD22 is a negative regulator of B-cell receptor signalling. Curr. Biol. 1997. 7: 133-143.
16. O'Keefe, T. L., Williams, G. T., Batista, F. D. and Neuberger, M. S., Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J. Exp. Med. 1999. 189: 1307-1313.
17. Lipsky, P. E., Systemic lupus erythernatosus: An autoimmune disease of B cell hyperactivity. Nat. Immunol. 2001. 2: 764-766.
18. Mary, C., Laporte, C., Parzy, D., Santiago, M. L., Stefani, F., Lajaunias, F., Parkhouse, R. M. et al., Dysregulated expression of the Cd22 gene as a result of a short interspersed nucleotide element insertion in Cd22a lupus-prone mice. J. Immunol. 2000. 165: 2987-2996.
19. Pritchard, N. R. and Smith, K. G., B cell inhibitory receptors and autoimmunity. Immunology 2003. 108: 263-273.
20. Pewzner-Jung, Y., Friedmann, D., Sonoda, E., Jung, S., Rajewsky, K. and Eilat, D., B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain. J. Immunol. 1998. 161: 4634-4645.
21. Yachimovich, N., Mostoslavsky, G., Yarkoni, Y., Verbovetski, I. and Eilat, D., The efficiency of B cell receptor (BCR) editing is dependent on BCR light chain rearrangement status. Eur. J. Immunol. 2002. 32: 1164-1174.
22. Burnet, F. M., The clonal selection theory of acquired immunity. Cambridge University Press, Cambridge 1959
23. Nossal, G. J., Clonal anergy of B cells: A flexible, reversible, and quantitative concept. J. Exp. Med. 1996-183: 1953-1956.
24. Nemazee, D. and Weigert, M., Revising B cell receptors. J. Exp. Med. 2000. 191: 1813-1817.
25. Lang, J., Jackson, M., Teyton, L., Brunmark, A., Kane, K. and Nemazee, D., B cells are exquisitely sensitive to central tolerance and receptor editing induced by ultralow affinity, membrane-bound antigen. J. Exp. Med. 1996. 184: 1685-1697.
26. Halverson, R., Torres, R. M. and Pelanda, R., Receptor editing is the main mechanism of B cell tolerance toward membrane antigens. Nat. Immunol. 2004. 5: 645-650.
27. Friedmann, D., Yachimovich, N., Mostoslavsky, G., Pewzner-Jung, Y., Ben-Yehuda, A., Rajewsky, K. and Eilat, D., Production of high affinity autoantibodies in autoimmune New Zealand black/New Zealand white F1 mice targeted with an anti-DNA heavy chain. J. Immunol. 1999. 162: 4406-4416.
28. Yachimovich-Cohen, N., Fischel, R., Bachar, N., Yarkoni, Y. and Eilat, D., Autoimmune NZB/NZW F1 mice utilize B cell receptor editing for generating high-affinity anti-dsDNA autoantibodies from low-affinity precursors. Eur. J. Immunol. 2003. 33: 2469-2478.
29. Pewzner-Jung, Y., Simon, T. and Eilat, D., Structural elements controlling anti-DNA antibody affinity and their relationship to anti-phosphorylcholine activity. J. Immunol. 1996. 156: 3065-3073.
30. Eilat, D., Webster, D. M. and Rees, A. R., V region sequences of anti-DNA and anti-RNA autoantibodies from NZB/NZW F1 mice. J. Immunol. 1988. 141: 1745-1753.
31. Liang, Z., Xie, C., Chen, C., Kreska, D., Hsu, K., Li, L., Zhou, X. J. and Mohan, C., Pathogenic profiles and molecular signatures of antinuclear autoantibodies rescued from NZM2410 lupus mice. J. Exp. Med. 2004. 199: 381-398.
32. Chen, C., Nagy, Z., Radic, M. Z., Hardy, R. R., Huszar, D., Camper, S. A. and Weigert, M., The site and stage of anti-DNA B-cell deletion. Nature 1995. 373: 252-255.
33. Jankovic, M., Casellas, R., Yannoutsos, N., Wardemann, H. and Nussenzweig, M. C., RAGs and regulation of autoantibodies. Annu. Rev. Immunol. 2004. 22: 485-501.
34. Schlissel, M., Constantinescu, A., Morrow, T., Baxter, M. and Peng, A., Double-strand signal sequence breaks in V(D)J recombination are blunt, 5′-phosphorylated, RAG-dependent, and cell cycle regulated. Genes Dev. 1993. 7: 2520-2532.
35. Brard, F., Shannon, M., Prak, E. L., Litwin, S. and Weigert, M., Somatic mutation and light chain rearrangement generate autoimmunity in anti-single-stranded DNA transgenic MRL/lpr mice. J. Exp. Med. 1999. 190: 691-704.
36. Wellmann, U., Letz, M., Herrmann, M., Angermuller, S., Kalden, J. R. and Winkler, T. H., The evolution of human anti-double-stranded DNA autoantibodies. Proc. Nad. Acad. Sci. USA 2005. 102: 9258-9263.
37. Mostoslavsky, G., Fischel, R., Yachimovich, N., Yarkoni, Y., Rosenmann, E., Monestier, M., Baniyash, M. and Eilat, D., Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: A case for tissue injury by molecular mimicry. Eur. J. Immunol. 2001. 31: 1221-1227.
38. Waters, S. T., McDuffie, M., Bagavant, H., Deshmukh, U. S., Gaskin, F., Jiang, C., Tung, K. S. and Fu, S. M., Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis. J. Exp. Med. 2004. 199. 255-264.
39. Christensen, S. R., Kashgarian, M., Alexopoulou, L., Flavell, R. A., Akira, S. and Shlomchik, M. J., Toll-like receptor 9 controls anti-DNA autoanti-body production in murine lupus. J. Exp. Med. 2005. 202: 321-331.
40. Poe, J. C., Fujimoto, Y., Hasegawa, M., Haas, K. M., Miller, A. G., Sanford, I. G., Bock, C. B. et al., CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms. Nat. Immunol 2004. 5: 1078-1087.
41. Sato, S., Miller, A. S., Inaoki, M., Bock, C. B., Jansen, P. J., Tang, M. L. K. and Tedder, T. F., CD22 is both positive and negative regulator of B lymphocyte antigen receptor signal transduction: Altered signaling in CD22-deficient mice. Immunity 1996. 5: 551-562.
42. Gleichmann, E., Van Elven, E. H. and Van der Veen, J. P., A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE. Eur. J. Immunol. 1982. 12: 152-159.
43. Sekiguchi, D. R., Jainandunsing, S. M., Fields, M. L., Maldonado, M. A., Madaio, M. P., Erikson, J., Weigert, M. and Eisenberg, R. A., Chronic graft-versus-host in Ig knockin transgenic mice abrogates B cell tolerance in anti-double-stranded DNA B cells. J. Immunol. 2002. 168: 4142-4153.
44. Mackay, F., Woodcock, S. A., Lawton, P., Ambrose, C., Baetscher, M., Schneider, P., Tschopp, J. and Browning, J. L., Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 1999. 190: 1697-1710.
45. Nguyen, K. A., Mandik, L., Bui, A., Kavaler, J., Norvell, A., Monroe, J. G., Roark, J. H. and Erikson, J., Characterization of anti-single-stranded DNA B cells in a non-autoimmune background. J. Immunol. 1997. 159: 2633-2644.
46. Hannum, L. G., Ni, D., Haberman, A. M., Weigert, M. G. and Shlomchik, M. J., A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: Implications for the origins of autoantibodies in autoimmune disease. J. Exp. Med. 1996. 184: 1269-1278.
47. Wardemann, H., Yurasov, S., Schaefer, A., Young, J. W., Meffre, E. and Nussenzweig, M. C., Predominant autoantibody production by early human B cell precursors. Science 2003. 301: 1374-1377.
48. Yurasov, S., Wardemann, H., Hammersen, J., Tsuiji, M., Meffre, E., Pascual, V. and Nussenzweig, M. C., Defective B cell tolerance checkpoints in systemic lupus erythematosus. J. Exp. Med. 2005. 201: 703-711.
49. Hikida, M., Mori, M., Takai, T., Tomochika, K., Hamatani, K. and Ohmori, H., Reexpression of RAG-1 and RAG-2 genes in activated mature mouse B cells. Science 1996. 274: 2092-2094.
50. Han, S., Zheng, B., Schatz, D. G., Spanopoulou, E. and Kelsoe, G., Neoteny in lymphocytes: Rag1 and Rag2 expression in germinal center B cells. Science 1996. 274: 2094-2097.
51. Papavasiliou, F., Casellas, R., Sub, H., Qin, X. F., Besmer, E., Pelanda, R., Nemazee, D. et al., V(D)J recombination in mature B cells: A mechanism for altering antibody responses. Science 1997. 278: 298-301.
52. Monroe, R. J., Seidl, K. J., Gaertner, F., Han, S., Chen, F., Sekiguchi, J., Wang, J. et al., RAG2:GFP knockin mice reveal novel aspects of RAG2 expression in primary and peripheral lymphoid tissues. Immunity 1999. 11: 201-212.
53. Yu, W., Nagaoka, H., Jankovic, M., Misulovin, Z., Suh, H., Rolink, A., Melchers, F. et al., Continued RAG expression in late stages of B cell development and no apparent re-induction after immunization. Nature 1999. 400: 682-687.
54. Wakui, M., Kim, J., Butfiloski, E. J., Morel, L. and Sobel, E. S., Genetic dissection of lupus pathogenesis: Sle3/5 impacts IgH CDR3 sequences, somatic mutations, and receptor editing. J. Immunol. 2004. 173: 7368-7376.
55. Rice, J. S., Newman, J., Wang, C., Michael, D. J. and Diamond, B., Receptor editing in peripheral B cell tolerance. Proc. NatI. Acad. Sci. USA 2005. 102: 1608-1613.
56. Goodnow, C. C., Crosbie, J., Adelstein, S., Lavoie, T. B., Smith-Gill, S. J., Brink, R. A., Pritchard-Briscoe, H. et al., Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988. 334: 676-682.
57. Hartley, S. B., Crosbie, J., Brink, R., Kantor, A. B., Basten, A. and Goodnow, C. C., Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 1991. 353: 765-769.
58. Russell, D. M., Dembic, Z., Morahan, G., Miller, J. F., Burki, K. and Nemazee, D., Peripheral deletion of self-reactive B cells. Nature 1991. 354: 308-311.
59. Pulendran, B., Kannourakis, G., Nouri, S., Smith, K. G. and Nossal, G. J., Soluble antigen can cause enhanced apoptosis of germinal-centre B cells. Nature 1995. 375: 331-334.
60. Shokat, K. M. and Goodnow, C. C., Antigen-induced B-cell death and elimination during germinal-centre immune responses. Nature 1995. 375: 334-338.
61. Chung, J. B., Sater, R. A., Fields, M. L., Erikson, J. and Monroe, J. G., CD23 defines two distinct subsets of immature B cells which differ in their responses to T cell help signals. Int. Immunol. 2002. 14: 157-166.
62. Petro, J. B., Gerstein, R. M., Lowe, J., Carter, R. S., Shinners, N. and Khan, W. N., Transitional type 1 and 2 B lymphocyte subsets are differentially responsive to antigen receptor signaling. J. Biol. Chem. 2002. 277: 48009-48019.
63. Cook, M. C., Basten, A. and Fazekas de St Groth, B., Rescue of self-reactive B cells by provision of T cell help in vivo. Eur. J. Immunol. 1998. 28: 2549-2558.
64. Chen, C., Li, H., Tian, Q., Beardall, M., Xu, Y., Casanova, N. and Weigert, M., Selection of anti-double-stranded DNA B cells in autoimmune MRL-lpr/lpr mcie. J. Immunol. 2006. 176: 5183-5190.
65. Hippen, K. L., Schram, B. R., Tze, L. E., Pape, K. A., Jenkins, M. K. and Behrens, T. W., In vivo assessment of the relative contributions of deletion, anergy, and editing to B cell self-tolerance. J. Immunol. 2005. 175: 909-916.
66. Tze, L. E., Baness, E. A., Hippen, K. L. and Behrens, T. W., Ig light chain receptor editing in anergic B cells. J. Immunol. 2000. 165: 6796-6802.
67. Verkoczy, L. K, Martensson, A. S. and Nemazee, D., The scope of receptor editing and its association with autoimmunity. Curr. Opin. Immunol. 2004. 16: 808-814.
68. Rolink, A. G., Andersson, J. and Melchers, F., Characterization of immature B cells by a novel monoclonal antibody, by turnover and by mitogen reactivity. Eur. J. Immunol. 1998. 28: 3738-3748.
69. Strohal, R., Helmberg, A., Kroemer, G. and Kofler, R., Mouse Vk gene classification by nucleic acid sequence similarity. Immunogenetics 1989. 30: 475-493.
70. Holm, S., A simple sequentially rejective multiple test procedure. Scand. J. Statist. 1979. 6: 65-70.